journal article·2026-08Open access

Convergence of ocular organoids and microfluidic platforms for advanced disease modeling and drug screening: Next generation eye models

Farnaz Hosseini, Fatemeh Madani, Ghazal Aghaei, Roya Ilka, Mehdi Mirzaei, Sayyed Amirpooya Alemzadeh, Omid Pourdakan, Masood Naseripour, Khalil Ghasemi Falavarjani, Hosein Shahsavarani, Bita Mehravi

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Ocular Oncology and Treatments · Retinal Development and Disorders · Retinal Diseases and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis10.1016/S2214-109X(17)30293-0 ↗
2. Global estimates of visual impairment: 201010.1136/bjophthalmol-2011-300539 ↗
3. Pathogenesis of common ocular diseases10.1155/2015/734527 ↗
4. Prevalence and risk factors of age-related macular degeneration in South Korea: korea national health and nutrition examination survey10.1080/09286586.2024.2321892 ↗
5. Colombian ocular diseases epidemiology study (CODES): prevalence and sociodemographic characterization of refractive errors in Colombian eye care consultations10.1080/09286586.2024.2330386 ↗
6. In vitro cell models for ophthalmic drug development applications10.1089/biores.2016.0008 ↗
7. Looking into the eyes—in vitro models for ocular research10.3390/ijms23169158 ↗
8. Animal and cellular models of microphthalmia
9. Establishment of vascularized human retinal organoids from induced pluripotent stem cells
10. Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: current research and future perspectives10.1016/j.cytogfr.2017.11.005 ↗
11. Microfluidic outer blood–retinal barrier model for inducing wet age-related macular degeneration by hypoxic stress10.1039/D2LC00672C ↗
12. Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip10.1038/s41467-024-45456-z ↗
13. Tissue engineering of outer blood retina barrier for therapeutic development10.1016/j.cobme.2024.100538 ↗
14. Photostimulation improves maturation of human photoreceptors
15. Automation of organoid cultures: current protocols and applications, SLAS DISCOVERY: advancing the science of
16. Fda · 2025
17. Organoids-on-a-chip: microfluidic technology enables culture of organoids with enhanced tissue function and potential for disease modeling10.3389/fbioe.2025.1515340 ↗
18. Organoids and organ chips in ophthalmology10.1016/j.jtos.2020.11.004 ↗
19. Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform10.7554/eLife.46188 ↗
20. Engineering microfluidic organoid-on-a-chip platforms10.3390/mi10030165 ↗
21. Microfluidic organs-on-chips10.1038/nbt.2989 ↗
22. Organ-on-a-chip toxicology
23. Tissue chips–innovative tools for drug development and disease modeling10.1039/C7LC00462A ↗
24. Advances in organ-on-a-chip engineering10.1038/s41578-018-0034-7 ↗
25. The eye and visual nervous system: anatomy, physiology and toxicology10.1289/ehp.82441 ↗
26. Corneal blindness: prevention, treatment and rehabilitation, community
27. Ocular drug delivery: impact of in vitro cell culture models
28. A microengineered human corneal epithelium-on-a-chip for eye drops mass transport evaluation10.1039/C8LC00158H ↗
29. The pathophysiology and treatment of glaucoma: a review10.1001/jama.2014.3192 ↗
31. Functional architecture of the retina: development and disease10.1016/j.preteyeres.2014.06.003 ↗
32. The retinal pigment epithelium in visual function10.1152/physrev.00021.2004 ↗
33. The retinal pigment epithelium in health and disease10.2174/156652410793937813 ↗
34. Age‐related macular degeneration—clinical review and genetics update10.1111/cge.12206 ↗
35. Recent developments in age-related macular degeneration: a review10.2147/CIA.S143508 ↗
36. The dynamic nature of Bruch's membrane10.1016/j.preteyeres.2009.08.003 ↗
37. Evaluation of the blood–retinal barrier with optical coherence tomography
38. Cell culture models of the ocular barriers10.1016/j.ejpb.2005.01.009 ↗
39. Fabrication of polymeric biomaterials: a strategy for tissue engineering and medical devices10.1039/C5TB01370D ↗
40. Developmental and pathological angiogenesis10.1146/annurev-cellbio-092910-154002 ↗
41. Microvascular permeability of normal and neoplastic tissues10.1016/0026-2862(86)90018-X ↗
42. Effects of particle geometry for PLGA-based nanoparticles: preparation and in vitro/in vivo evaluation10.3390/pharmaceutics15010175 ↗
43. In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors10.1158/0008-5472.CAN-07-0684 ↗
44. Modeling angiogenesis with micro-and nanotechnology10.1039/C7LC00774D ↗
45. Microfabrication meets microbiology10.1038/nrmicro1616 ↗
46. Microfabrication in biology and medicine10.1146/annurev.bioeng.1.1.401 ↗
47. Zebrafish model in ophthalmology to study disease mechanism and drug discovery10.3390/ph14080716 ↗
48. In vitro models of angiogenesis and vasculogenesis in fibrin gel10.1016/j.yexcr.2013.06.006 ↗
49. Microfluidic co-cultures of retinal pigment epithelial cells and vascular endothelial cells to investigate choroidal angiogenesis10.1038/s41598-017-03788-5 ↗
50. Cell sources and methods for producing organotypic in vitro human tissue models
51. In vitro microvessels for the study of angiogenesis and thrombosis10.1073/pnas.1201240109 ↗
52. Microfluidic organ/body-on-a-chip devices at the convergence of biology and microengineering10.3390/s151229848 ↗
53. The present and future role of microfluidics in biomedical research10.1038/nature13118 ↗
54. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip10.1371/journal.pone.0150360 ↗
55. Role of in vitro models for development of ophthalmic delivery systems10.1615/CritRevTherDrugCarrierSyst.2021035222 ↗
56. Is it time to start transitioning from 2D to 3D cell culture?10.3389/fmolb.2020.00033 ↗
57. Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro10.1002/jcp.1041450202 ↗
58. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties10.1006/exer.1996.0020 ↗
59. Photoreceptor-like cells from reprogramming cultured Mammalian RPE cells
60. Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival10.1021/pr050420t ↗
61. R28 retinal precursor cells: the first 20 years
62. Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase10.1016/j.exer.2006.05.018 ↗
63. Toxicity of indocyanine green (ICG) in combination with light on retinal pigment epithelial cells and neurosensory retinal cells10.1080/02713680590959312 ↗
64. Recharacterization of the RGC-5 retinal ganglion cell line10.1167/iovs.09-3484 ↗
65. A forensic path to RGC-5 cell line identification: lessons learned10.1167/iovs.13-12085 ↗
66. Beta adrenergic antagonist permeation across cultured rabbit corneal epithelial cells grown on permeable supports10.1076/ceyr.17.2.125.5598 ↗
67. A novel in vivo corneal trans-epithelial electrical resistance measurement device10.1016/j.vascn.2015.08.153 ↗
68. Two clonal cell lines of immortalized human corneal endothelial cells show either differentiated or precursor cell characteristics10.1159/000113406 ↗
69. Mucin gene expression in immortalized human corneal–limbal and conjunctival epithelial cell lines10.1167/iovs.02-0851 ↗
70. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva10.1167/iovs.03-0560 ↗
71. Human immunocompetent choroid-on-chip: a novel tool for studying ocular effects of biological drugs10.1038/s42003-021-02977-3 ↗
72. One-stop assembly of adherent 3D retinal organoids from hiPSCs based on 3D-printed derived PDMS microwell platform10.1088/1758-5090/acc761 ↗
73. Human retinal organoids provide a suitable tool for toxicological investigations: a comprehensive validation using drugs and compounds affecting the retina10.1093/stcltm/szab010 ↗
74. Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids10.1242/dev.146290 ↗
75. Discovery of novel selenium derivatives as Pin1 inhibitors by high-throughput screening10.1016/j.bbrc.2016.04.124 ↗
76. High-throughput imaging: focusing in on drug discovery in 3D10.1016/j.ymeth.2015.11.013 ↗
77. Human-induced pluripotent stem cells generate light responsive retinal organoids with variable and nutrient-dependent efficiency10.1002/stem.2883 ↗
78. Application of the organ-on-a-chip technology in experimental ophthalmology, Vestn10.17116/oftalma2023139011114 ↗
79. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment10.1002/stem.674 ↗
80. Self-organizing optic-cup morphogenesis in three-dimensional culture10.1038/nature09941 ↗
81. Wet‐AMD on a chip: modeling outer blood‐retinal barrier in vitro
82. A model microfluidics-based system for the human and mouse retina10.1007/s10544-015-0002-6 ↗
83. Generation of storable retinal organoids and retinal pigmented epithelium from adherent human iPS cells in xeno-free and feeder-free conditions10.1002/stem.2586 ↗
84. Optic vesicle‐like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment10.1002/stem.674 ↗
85. Reproducibility and staging of 3D human retinal organoids across multiple pluripotent stem cell lines
86. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs10.1038/ncomms5047 ↗
87. Characterization of three-dimensional retinal tissue derived from human embryonic stem cells in adherent monolayer cultures10.1089/scd.2015.0144 ↗
88. Generation of retinal ganglion cells with functional axons from mouse embryonic stem cells and induced pluripotent stem cells10.1167/iovs.16-19166 ↗
89. Modeling glaucoma: retinal ganglion cells generated from induced pluripotent stem cells of patients with SIX6 risk allele show developmental abnormalities10.1002/stem.2675 ↗
90. Self-formation of optic cups and storable stratified neural retina from human ESCs10.1016/j.stem.2012.05.009 ↗
91. Modeling the neurovascular niche: VEGF‐and BDNF‐mediated cross‐talk between neural stem cells and endothelial cells: an in vitro study10.1002/jnr.21087 ↗
92. A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks in vivo10.1073/pnas.0506020102 ↗
93. Accelerated and improved differentiation of retinal organoids from pluripotent stem cells in rotating-wall vessel bioreactors10.1016/j.stemcr.2017.11.001 ↗
94. Deciphering retinal diseases through the generation of three dimensional stem cell-derived organoids: concise review10.1002/stem.3089 ↗
95. Organoids and microphysiological systems: new tools for ophthalmic drug discovery10.3389/fphar.2020.00407 ↗
96. Modelling neurodegeneration and inflammation in early diabetic retinopathy using 3D human retinal organoids10.1007/s44164-024-00068-1 ↗
97. Retinal synaptic regeneration via microfluidic guiding channels
98. A model microfluidics-based system for the human and mouse retina10.1007/s10544-015-0002-6 ↗
99. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris10.1073/pnas.0905010106 ↗
100. Controlled cocultures of HeLa cells and human umbilical vein endothelial cells on detachable substrates10.1039/B812510D ↗